Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Vascular Health and Risk Management|November 22, 2013
Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational studyJochen Seufert, Katrin Pegelow, Peter Bramlage
BMJ Open Diabetes Research & Care|October 24, 2019
Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimenJochen Seufert, Anja Borck, Peter Bramlage
Journal of Diabetes Research|April 28, 2026
Weight Loss Strategies Associated With Type 2 Diabetes Duration: A Population-Based Optimal Intervention Window From the NHANESMaximilian Andreas Storz, Roman Huber, Jochen Seufert
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|January 30, 2007
[GC-box is not a key cis-acting element in human insulin gene promoter]Xin-Jie Niu, Zuo-Ren Wang, Jochen Seufert
Diabetes|January 30, 2004
Nuclear protein p8 is associated with glucose-induced pancreatic beta-cell growthGünter Päth, Anne Opel, Anita Knoll, et al.
Deutsche Medizinische Wochenschrift (1946)|October 10, 2025
[Interdisciplinary strategies for the prevention and treatment of MASLD]Natascha Röhlen, Katharina Laubner, Jochen Seufert, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 22, 2020
Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 UpdateMarkolf Hanefeld, Holger Fleischmann, Thorsten Siegmund, et al.
Lipids in Health and Disease|December 16, 2022
PCSK9 inhibition and cholesterol homeostasis in insulin producing β-cellsGünter Päth, Nikolaos Perakakis, Christos S Mantzoros, et al.
Metabolism: Clinical and Experimental|October 21, 2018
Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cellsGünter Päth, Nikolaos Perakakis, Christos S Mantzoros, et al.
Clinical Therapeutics|July 21, 2004
A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitusJochen Seufert, Georg Lübben, Karin Dietrich, et al.
Pageof 15